Life-Science New Build Report: 200 North American Sites in Planning Represent Potential $15 Billion Investment

SUGAR LAND--November 4, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It has become difficult, if not nearly impossible, for many of America's politicians to find common ground at any level. The outlier in this case appears to be the courting and landing of new life science industry facilities. In North America alone, there are currently 200 reported new-facility builds on the books, representing a total investment value of $15.4 billion.

Within this article: Details on the Pharmaceutical-Biotech Industry, including projects from such heavyweights as Baxter International Incorporated (NYSE:BAX), Gilead Sciences and Cosmax US Corporation.